Since MYCN expression is well known to be suppressed in differentiating NB cells by TrkA activation with its ligand, NGF, and high TrkA expression in primary NB was associated with favorable clinical features and inversely associated with MYCN amplification [10, 38]. This evidence concerns the gene MYCN and neuroblastoma.